PAPER Hong S, Dobricic V, Ohlei O, Bos I, Vos SJ, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Gabel S, Scheltens P, Teunissen CE, Engelborghs S, Frisoni G, Blin O, Richardson JC, Bordet R, Alzheimer's Disease Neuroimaging Initiative (ADNI), Lleó A, Alcolea D, Popp J, Clark C, Peyratout G, Martinez-Lage P, Tainta M, Dobson RJ, Legido-Quigley C, Sleegers K, Van Broeckhoven C, Tanzi RE, Ten Kate M, Wittig M, Franke A, Lill CM, Barkhof F, Lovestone S, Streffer J, Zetterberg H, Visser PJ, Bertram L

TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.

Alzheimers Dement. 2021 Oct;17(10):1628-1640. Epub 2021 May 14 PubMed: 33991015

PAPER Dickson JR, Yoon H, Frosch MP, Hyman BT

Cytoplasmic Mislocalization of RNA Polymerase II Subunit RPB1 in Alzheimer Disease Is Linked to Pathologic Tau.

J Neuropathol Exp Neurol. 2021 Jun 4;80(6):530-540. PubMed: 33990839

PAPER Chen Z, Zhang H, Guo Y, George TJ, Prosperi M, Hogan WR, He Z, Shenkman EA, Wang F, Bian J

Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer's disease.

NPJ Digit Med. 2021 May 14;4(1):84. PubMed: 33990663

PAPER Kim M, Kim SJ, Park JE, Yun J, Shim WH, Oh JS, Oh M, Roh JH, Seo SW, Oh SJ, Kim JS

Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer's disease.

Sci Rep. 2021 May 14;11(1):10343. PubMed: 33990649

PAPER Álvarez-Marimon E, Castillo-Michel H, Reyes-Herrera J, Seira J, Aso E, Carmona M, Ferrer I, Cladera J, Benseny-Cases N

Synchrotron X-ray Fluorescence and FTIR Signatures for Amyloid Fibrillary and Nonfibrillary Plaques.

ACS Chem Neurosci. 2021 Jun 2;12(11):1961-1971. Epub 2021 May 14 PubMed: 33990138

PAPER Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, Wong DY, Duarte Folle A, Markovic D, Palma JA, Serrano GE, Adler CH, Perlman SL, Poon WW, Kang UJ, Alcalay RN, Sklerov M, Gylys KH, Kaufmann H, Fogel BL, Bronstein JM, Ritz B, Bitan G

α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.

Acta Neuropathol. 2021 Sep;142(3):495-511. Epub 2021 May 15 PubMed: 33991233

Jason Pearson

Independence, United States

Elizabeth Yurth

Boulder, United States

Go to another page:

1
2
3
4
5
... 107

Current Filters

Date Range : Apr 2021 to May 2021 x

Remove all filters

SEARCH RESULTS

Deep recurrent model for individualized prediction of Alzheimer's disease progression.

Pesticides and Parkinson's disease: Current and future perspective.

The significance of sialylation on the pathogenesis of Alzheimer's disease.

In-vitro evaluation of antioxidant and anticholinesterase activities of novel pyridine, quinoxaline and s-triazine derivatives.

Investigation of therapeutic effect of curcumin α and β glucoside anomers against Alzheimer's disease by the nose to brain drug delivery.

Differential Influence of Amyloid-β on the Kinetics of Dopamine Release in the Dorsal and Ventral Striatum of Rats.

Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.